Your Behavioral Health has been acquired by Comvest Partners
Your Behavioral Health (YBH) has been sold to Comvest Partners.
YBH is a provider of comprehensive behavioral health treatments under the Clear Recovery Center, Neuro Wellness Spa, and New Life House brands, providing mental health and addiction treatment services for adults and teens. YBH provides the full spectrum of clinical inpatient, outpatient, interventional psychiatry and residential care across its family of brands and delivers specialized programs for depression, anxiety, trauma-related issues, addiction and other mental health conditions. Together under the YBH platform and the leadership of its visionary founders, Chief Executive Officer Mike Joly and Medical Director Dr. Martha Koo, the three programs provide highly differentiated care across the continuum of behavioral health through a fast-growing footprint that currently includes 17 premier locations across Southern California.
Comvest Partners is a private investment firm providing equity and debt capital to middle-market companies across North America. Since its founding in 2000, Comvest has invested over US$11.7 billion. Today, Comvest has over US$9.9 billion of assets under management. Through its private equity, direct lending and special opportunities investment strategies, the company offers tailored investment solutions across the capital structure, extensive capital resources and deep industry and operating expertise that help well-positioned companies successfully achieve their goals for growth.
Oaklins Intrepid in Los Angeles acted as the exclusive sell-side advisor in this transaction.
Prata med transaktionsteamet
Relaterade transaktioner
Medicija has acquired Saulės Šeimos Medicinos Centras
Medicija has acquired a 100% stake in Saulės Šeimos Medicinos Centras.
Lär dig merQuimpharma has completed the divestiture of a product portfolio to Megalabs
Quimpharma has completed the divestiture of a product portfolio to Megalabs México.
Lär dig merIXICO has completed a fundraising
IXICO plc, a specialist in AI-driven neuroimaging analytics, has completed a US$13.5 million gross capital raise. The funds will be used to support the company’s tech bio strategy, which will see IXICO partner its platform to maximize its potential.
Lär dig mer